<DOC>
	<DOC>NCT01199341</DOC>
	<brief_summary>The primary purpose of this study is to determine whether the treatment with AZD1981 affect the exposure of Warfarin.</brief_summary>
	<brief_title>A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Have a body mass index between 19 and 30 kg/m2 and weight at least 65 kg and no more than 100 kg Be a nonsmoker or exsmoker who has stopped smoking for &gt;6 months prior to screening Volunteers must be willing to use barrier methods of contraception during study and 3 months after the end of their participation in the study Volunteer that is inferred to have an increased sensitivity to warfarin based on genotype of CYP2C9 and VKORC1. Any clinically significant disease or disorder Any clinically relevant abnormal findings in physical examination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Drug-Drug interaction</keyword>
	<keyword>warfarin</keyword>
	<keyword>AZD1981</keyword>
</DOC>